0.10Open0.10Pre Close0 Volume78 Open Interest5.00Strike Price0.00Turnover9598.68%IV277.78%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.2005Delta0.2112Gamma13.50Leverage Ratio-4.7834Theta0.0000Rho2.71Eff Leverage0.0000Vega
Renovaro Stock Discussion
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
No comment yet